Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Watchlist
Price: 701.85 USD -0.9% Market Closed
Market Cap: 77.1B USD
Have any thoughts about
Regeneron Pharmaceuticals Inc?
Write Note

Income Statement

Earnings Waterfall
Regeneron Pharmaceuticals Inc

Revenue
13.8B USD
Cost of Revenue
-1.8B USD
Gross Profit
12B USD
Operating Expenses
-7.8B USD
Operating Income
4.2B USD
Other Expenses
461.6m USD
Net Income
4.7B USD

Income Statement
Regeneron Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
2 628
N/A
2 820
+7%
3 063
+9%
3 396
+11%
3 808
+12%
4 104
+8%
4 435
+8%
4 649
+5%
4 732
+2%
4 860
+3%
4 979
+2%
5 236
+5%
5 517
+5%
5 872
+6%
6 065
+3%
6 203
+2%
6 365
+3%
6 711
+5%
6 572
-2%
6 542
0%
6 622
+1%
7 863
+19%
7 319
-7%
7 693
+5%
8 244
+7%
8 497
+3%
9 198
+8%
12 384
+35%
13 543
+9%
16 072
+19%
16 508
+3%
14 227
-14%
13 710
-4%
12 173
-11%
12 370
+2%
12 671
+2%
13 097
+3%
13 117
+0%
13 100
0%
13 489
+3%
13 847
+3%
Gross Profit
Cost of Revenue
(194)
(205)
(246)
(288)
(341)
(393)
(421)
(401)
(336)
(300)
(272)
(306)
(366)
(397)
(428)
(417)
(423)
(434)
(491)
(546)
(661)
(782)
(813)
(942)
(991)
(1 120)
(1 211)
(1 629)
(1 808)
(2 438)
(2 534)
(2 138)
(2 002)
(1 560)
(1 613)
(1 721)
(1 839)
(1 714)
(1 690)
(1 765)
(1 820)
Gross Profit
2 434
N/A
2 615
+7%
2 818
+8%
3 109
+10%
3 467
+12%
3 711
+7%
4 014
+8%
4 248
+6%
4 396
+3%
4 561
+4%
4 706
+3%
4 930
+5%
5 151
+4%
5 475
+6%
5 637
+3%
5 786
+3%
5 943
+3%
6 277
+6%
6 081
-3%
5 996
-1%
5 961
-1%
7 081
+19%
6 507
-8%
6 751
+4%
7 253
+7%
7 377
+2%
7 987
+8%
10 755
+35%
11 735
+9%
13 634
+16%
13 974
+2%
12 089
-13%
11 708
-3%
10 613
-9%
10 757
+1%
10 950
+2%
11 258
+3%
11 404
+1%
11 410
+0%
11 724
+3%
12 027
+3%
Operating Income
Operating Expenses
(1 614)
(1 791)
(1 902)
(2 076)
(2 230)
(2 459)
(2 735)
(3 006)
(3 183)
(3 230)
(3 274)
(3 239)
(3 263)
(3 396)
(3 421)
(3 498)
(3 588)
(3 742)
(3 633)
(3 856)
(3 709)
(4 872)
(4 077)
(3 981)
(4 168)
(3 801)
(3 998)
(4 075)
(4 261)
(4 687)
(4 853)
(5 009)
(5 251)
(5 619)
(6 047)
(6 530)
(6 851)
(7 068)
(7 319)
(7 556)
(7 834)
Selling, General & Administrative
(426)
(519)
(575)
(653)
(719)
(839)
(969)
(1 087)
(1 147)
(1 178)
(1 185)
(1 200)
(1 236)
(1 320)
(1 354)
(1 412)
(1 475)
(1 556)
(1 517)
(1 446)
(1 381)
(1 835)
(1 553)
(1 607)
(1 629)
(1 346)
(1 384)
(1 451)
(1 569)
(1 825)
(1 869)
(1 931)
(2 015)
(2 116)
(2 267)
(2 443)
(2 554)
(2 631)
(2 719)
(2 826)
(2 900)
Research & Development
(1 188)
(1 271)
(1 327)
(1 423)
(1 511)
(1 621)
(1 748)
(1 917)
(2 034)
(2 052)
(2 090)
(2 040)
(2 026)
(2 075)
(2 066)
(2 086)
(2 113)
(2 186)
(2 179)
(2 535)
(2 504)
(3 037)
(2 679)
(2 515)
(2 674)
(2 735)
(2 894)
(2 886)
(2 867)
(2 908)
(3 009)
(3 089)
(3 335)
(3 593)
(3 850)
(4 141)
(4 305)
(4 439)
(4 586)
(4 701)
(4 897)
Other Operating Expenses
0
0
0
0
0
0
(18)
0
0
0
0
0
0
0
0
0
0
0
62
125
176
0
155
141
135
280
281
262
175
46
25
11
99
90
70
53
8
2
(14)
(29)
(37)
Operating Income
820
N/A
823
+0%
916
+11%
1 033
+13%
1 237
+20%
1 252
+1%
1 280
+2%
1 242
-3%
1 213
-2%
1 331
+10%
1 432
+8%
1 691
+18%
1 888
+12%
2 080
+10%
2 216
+7%
2 288
+3%
2 355
+3%
2 534
+8%
2 447
-3%
2 141
-13%
2 252
+5%
2 210
-2%
2 430
+10%
2 771
+14%
3 085
+11%
3 577
+16%
3 989
+12%
6 680
+67%
7 474
+12%
8 947
+20%
9 121
+2%
7 080
-22%
6 457
-9%
4 994
-23%
4 710
-6%
4 420
-6%
4 407
0%
4 336
-2%
4 091
-6%
4 168
+2%
4 193
+1%
Pre-Tax Income
Interest Income Expense
(43)
(37)
(32)
(25)
(17)
(14)
(11)
(10)
(9)
(7)
(13)
(17)
(23)
(25)
(24)
(26)
(27)
14
13
(105)
(89)
88
(127)
217
145
139
331
508
528
329
(25)
(597)
(314)
(20)
118
363
140
172
209
698
990
Non-Reccuring Items
(11)
(33)
(34)
(40)
(40)
(19)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(28)
(225)
(225)
(255)
(283)
(86)
(186)
(288)
(239)
(263)
(220)
Total Other Income
3
8
7
8
8
6
10
11
11
6
13
(9)
(0)
24
39
99
104
5
54
47
53
131
248
259
245
95
74
41
45
50
67
86
120
140
111
79
16
(20)
(19)
(15)
6
Pre-Tax Income
770
N/A
761
-1%
857
+13%
976
+14%
1 188
+22%
1 225
+3%
1 279
+4%
1 243
-3%
1 216
-2%
1 330
+9%
1 432
+8%
1 666
+16%
1 865
+12%
2 079
+11%
2 232
+7%
2 362
+6%
2 432
+3%
2 554
+5%
2 514
-2%
2 083
-17%
2 216
+6%
2 429
+10%
2 552
+5%
3 246
+27%
3 476
+7%
3 810
+10%
4 395
+15%
7 229
+64%
8 047
+11%
9 326
+16%
9 134
-2%
6 344
-31%
6 038
-5%
4 859
-20%
4 656
-4%
4 775
+3%
4 376
-8%
4 199
-4%
4 042
-4%
4 587
+13%
4 969
+8%
Net Income
Tax Provision
(425)
(423)
(511)
(532)
(616)
(589)
(537)
(500)
(418)
(434)
(469)
(511)
(587)
(554)
(478)
(444)
(320)
(177)
(155)
(82)
(127)
(313)
(272)
(262)
(320)
(297)
(391)
(1 023)
(1 052)
(1 251)
(1 200)
(658)
(667)
(520)
(473)
(476)
(385)
(246)
(184)
(266)
(315)
Income from Continuing Operations
345
338
346
444
571
636
741
743
797
896
963
1 155
1 278
1 525
1 754
1 917
2 112
2 376
2 360
2 001
2 088
2 116
2 279
2 984
3 156
3 513
4 004
6 205
6 996
8 075
7 934
5 687
5 370
4 338
4 183
4 299
3 991
3 954
3 858
4 322
4 655
Net Income (Common)
345
N/A
338
-2%
346
+2%
444
+28%
571
+29%
636
+11%
741
+17%
743
+0%
797
+7%
896
+12%
963
+7%
1 155
+20%
1 278
+11%
1 199
-6%
1 428
+19%
1 591
+11%
1 798
+13%
2 444
+36%
2 428
-1%
2 069
-15%
2 144
+4%
2 116
-1%
2 279
+8%
2 984
+31%
3 156
+6%
3 513
+11%
4 004
+14%
6 205
+55%
6 996
+13%
8 075
+15%
7 934
-2%
5 687
-28%
5 370
-6%
4 338
-19%
4 183
-4%
4 299
+3%
3 991
-7%
3 954
-1%
3 858
-2%
4 322
+12%
4 655
+8%
EPS (Diluted)
2.93
N/A
2.98
+2%
3.01
+1%
3.85
+28%
4.92
+28%
5.52
+12%
6.49
+18%
6.39
-2%
6.84
+7%
7.72
+13%
8.36
+8%
9.96
+19%
10.92
+10%
10.33
-5%
12.42
+20%
13.89
+12%
15.61
+12%
21.25
+36%
21.01
-1%
18.05
-14%
18.77
+4%
18.39
-2%
19.8
+8%
25.3
+28%
27.7
+9%
30.54
+10%
36.23
+19%
56
+55%
61.41
+10%
72.09
+17%
70.14
-3%
49.88
-29%
47.6
-5%
38.05
-20%
36.69
-4%
37.74
+3%
35.19
-7%
34.77
-1%
33.51
-4%
37.44
+12%
40.05
+7%

See Also

Discover More